Semaglutide
OZEMPIC, RYBELSUS, WEGOVY
GLP-1 Receptor Agonist
NADAC/unit
$33.1602
No Shortage
Tier 1: 113.4%
PA Req: 603.0%
Semaglutide lowers blood sugar and promotes weight loss by mimicking the GLP-1 hormone, used in type 2 diabetes.
vs. brand OZEMPIC: Generic saves up to -232% per unit
Market Intelligence
2026-01-07 Class II Recall: Novo Nordisk Inc.
2026-01-07 Class II Recall: Novo Nordisk Inc.
2025-05-07 Class II Recall: Cardinal Health Inc.
Generic Manufacturers
NOVO NORDISK INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.